Pediatric ASPECTS predicts outcomes following acute symptomatic neonatal arterial stroke.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
24 03 2020
Historique:
received: 10 04 2019
accepted: 05 11 2019
pubmed: 23 2 2020
medline: 24 7 2020
entrez: 21 2 2020
Statut: ppublish

Résumé

To test the hypothesis that the Alberta Stroke Program Early Computed Tomography Score (ASPECTS) is useful in determining outcomes after neonatal arterial ischemic stroke (NAIS), we assessed accuracy of the modified pediatric ASPECTS (pedASPECTS) to predict cerebral palsy (CP), neurologic impairment, and epilepsy. Cross-sectional study included newborns with acute NAIS whose outcomes were assessed at ≥18 months after stroke. PedASPECTS accuracy to predict outcomes was determined by sensitivity, specificity, and receiver operator characteristic (ROC) curves, and correlation between pedASPECTS and infarct volume was determined by the Spearman correlation coefficient. Ninety-six children met the inclusion criteria. Median percentage infarct to supratentorial brain volume was 6.8% (interquartile range [IQR] 3.0%-14.3%). Median pedASPECTS was 7 (IQR 4-10). At a median age of 2.1 years, 35% developed CP, 43% had neurologic impairment, and 7% had epilepsy. Median pedASPECTS predicted outcomes of interest: CP (10, IQR 8-12) vs no CP (5, IQR 4-8) ( This study provides Class II evidence that pedASPECTS has fair to good accuracy for predicting CP, neurologic impairment, and epilepsy after NAIS and correlates with infarct volume. PedASPECTS may assist with early identification of babies requiring close developmental surveillance.

Identifiants

pubmed: 32075895
pii: WNL.0000000000009136
doi: 10.1212/WNL.0000000000009136
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1259-e1270

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 American Academy of Neurology.

Auteurs

Mark T Mackay (MT)

From the Department of Neurology (M.T.M., B.S.), Royal Children's Hospital; Murdoch Children's Research Institute (M.T.M., B.S., S.D.); Florey Institute of Neurosciences and Mental Health (M.T.M., S.D.); University of Melbourne (M.T.M.), Parkville, Australia; Support Center for Advanced Neuroimaging (N.S., M.P.-W.), Institute of Diagnostic and Interventional Neuroradiology, University Hospital, Inselspital; and Division of Neuropaediatrics, Development and Rehabilitation (M.P.-W., S.G., M.S.), Children's University Hospital, Inselspital, Bern, Switzerland. mark.mackay@rch.org.au.

Nedelina Slavova (N)

From the Department of Neurology (M.T.M., B.S.), Royal Children's Hospital; Murdoch Children's Research Institute (M.T.M., B.S., S.D.); Florey Institute of Neurosciences and Mental Health (M.T.M., S.D.); University of Melbourne (M.T.M.), Parkville, Australia; Support Center for Advanced Neuroimaging (N.S., M.P.-W.), Institute of Diagnostic and Interventional Neuroradiology, University Hospital, Inselspital; and Division of Neuropaediatrics, Development and Rehabilitation (M.P.-W., S.G., M.S.), Children's University Hospital, Inselspital, Bern, Switzerland.

Manuela Pastore-Wapp (M)

From the Department of Neurology (M.T.M., B.S.), Royal Children's Hospital; Murdoch Children's Research Institute (M.T.M., B.S., S.D.); Florey Institute of Neurosciences and Mental Health (M.T.M., S.D.); University of Melbourne (M.T.M.), Parkville, Australia; Support Center for Advanced Neuroimaging (N.S., M.P.-W.), Institute of Diagnostic and Interventional Neuroradiology, University Hospital, Inselspital; and Division of Neuropaediatrics, Development and Rehabilitation (M.P.-W., S.G., M.S.), Children's University Hospital, Inselspital, Bern, Switzerland.

Sebastian Grunt (S)

From the Department of Neurology (M.T.M., B.S.), Royal Children's Hospital; Murdoch Children's Research Institute (M.T.M., B.S., S.D.); Florey Institute of Neurosciences and Mental Health (M.T.M., S.D.); University of Melbourne (M.T.M.), Parkville, Australia; Support Center for Advanced Neuroimaging (N.S., M.P.-W.), Institute of Diagnostic and Interventional Neuroradiology, University Hospital, Inselspital; and Division of Neuropaediatrics, Development and Rehabilitation (M.P.-W., S.G., M.S.), Children's University Hospital, Inselspital, Bern, Switzerland.

Belinda Stojanovski (B)

From the Department of Neurology (M.T.M., B.S.), Royal Children's Hospital; Murdoch Children's Research Institute (M.T.M., B.S., S.D.); Florey Institute of Neurosciences and Mental Health (M.T.M., S.D.); University of Melbourne (M.T.M.), Parkville, Australia; Support Center for Advanced Neuroimaging (N.S., M.P.-W.), Institute of Diagnostic and Interventional Neuroradiology, University Hospital, Inselspital; and Division of Neuropaediatrics, Development and Rehabilitation (M.P.-W., S.G., M.S.), Children's University Hospital, Inselspital, Bern, Switzerland.

Susan Donath (S)

From the Department of Neurology (M.T.M., B.S.), Royal Children's Hospital; Murdoch Children's Research Institute (M.T.M., B.S., S.D.); Florey Institute of Neurosciences and Mental Health (M.T.M., S.D.); University of Melbourne (M.T.M.), Parkville, Australia; Support Center for Advanced Neuroimaging (N.S., M.P.-W.), Institute of Diagnostic and Interventional Neuroradiology, University Hospital, Inselspital; and Division of Neuropaediatrics, Development and Rehabilitation (M.P.-W., S.G., M.S.), Children's University Hospital, Inselspital, Bern, Switzerland.

Maja Steinlin (M)

From the Department of Neurology (M.T.M., B.S.), Royal Children's Hospital; Murdoch Children's Research Institute (M.T.M., B.S., S.D.); Florey Institute of Neurosciences and Mental Health (M.T.M., S.D.); University of Melbourne (M.T.M.), Parkville, Australia; Support Center for Advanced Neuroimaging (N.S., M.P.-W.), Institute of Diagnostic and Interventional Neuroradiology, University Hospital, Inselspital; and Division of Neuropaediatrics, Development and Rehabilitation (M.P.-W., S.G., M.S.), Children's University Hospital, Inselspital, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH